- advertisement -

Generex Announces Governmental Approval of its Oral Insulin Spray Product in Lebanon

Discussion in 'The Middle East' started by binmoosa, Dec 30, 2008.

  1. binmoosa

    binmoosa Approved members

    Mar 11, 2007
    WORCESTER, Mass., Dec. 23, 2008 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that Lebanon's Ministry of Public Health has approved Generex Oral-lyn, the Company's proprietary oral insulin spray product, for importation, marketing, distribution, and commercial sale in the Republic of Lebanon for the treatment of adults and children with Type-1 or Type-2 diabetes mellitus.

    Benta SAL (www.bpi.com.lb), the Company's licensee in Lebanon and the holder of the largest market share in the supply of pharmaceuticals, medical supplies, and equipment to Lebanese hospitals and public health institutions, is poised to commence the marketing and sale of Generex Oral-lyn in Lebanon early in 2009.


Share This Page

- advertisement -

  1. This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
    By continuing to use this site, you are consenting to our use of cookies.
    Dismiss Notice